Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novartis patents antibacterial quinolone derivatives

Feb. 17, 2016

Siena Biotech and Roche report BACE1 inhibitors

Feb. 16, 2016

Gilead Sciences discloses antiviral agents

Feb. 16, 2016

Roche divulges TaR-1 ligands

Feb. 16, 2016

Sunshine Lake Pharma patents CDK4 and/or CDK6 inhibitors

Feb. 16, 2016

Janssen Pharmaceutica divulges mGlu2 receptor modulators

Feb. 15, 2016

Merck & Co. reports development of CETP inhibitors

Feb. 15, 2016

Roche patent describes TaR-1 ligands

Feb. 15, 2016

Ferrer discloses antibacterial agents

Feb. 15, 2016

Boehringer Ingelheim Pharma patents DPP-I inhibitors

Feb. 15, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...